Walgreens outlines $1 billion in cost reductions as profit projection disappoints

Walgreens outlines  billion in cost reductions as profit projection disappoints

CompaniesWalgreen ⁢CoFollowWalgreens Health ServicesFollowCigna GroupFollowShow more companiesOct ‌12 (Reuters) – Walgreens Boots Alliance ‍(WBA.O) said on ​Thursday that it expected to cut at least $1 billion in ⁣costs in 2024⁢ as part of its ongoing efforts,⁤ which include shutting unprofitable ‌stores, after‍ the ​pharmacy chain ⁣operator​ forecast financial ‌year 2024 profit‌ below Wall Street’s expectations.Shares⁢ of the company ⁤rose 5% in early trading, paring earlier premarket losses after it highlighted more cost-cutting measures, like using‌ artificial intelligence to make its supply chain more efficient.It ‌is⁤ also lowering its capital⁢ expenditure by about $600⁢ million. Its shares have fallen‌ nearly 40% so far this year.Walgreens ​has been contending with a steep drop in sales of COVID-19 products, persistently weak prescription drug⁤ demand, reported walkouts‍ by its store staff and weak sales ⁢of‍ its⁣ consumer health products due⁤ to high⁢ inflation.Its adjusted profit of 67 cents per share in the⁢ fourth quarter ‍also⁢ missed ⁤the LSEG estimate of 69 cents per share.”Our performance this year has not reflected WBA’s strong ⁤assets, brand legacy, or our commitment to our customers and patients,” Interim CEO Ginger Graham said in a statement.The company recorded a $6.8 billion pre-tax ‍charge for opioid-related claims and litigation during the last financial year.Walgreens had ‍said ⁤in June it would‍ close its stores‍ at‌ 150 locations in ‍the United States. It also ​named Tim⁤ Wentworth, a former ‍Cigna (CI.N) executive, as permanent ⁣CEO on Tuesday.The second-largest U.S. pharmacy chain⁣ operator, ⁣whose financial year ends​ in August, ‍forecast an annual adjusted profit of $3.20 to $3.50 per share, compared to analysts’ average estimate of ​$3.72 per share, ⁢according to LSEG data.In the fourth quarter, the company reported a 4.3% fall‍ in U.S. retail sales and a 0.5% decline in total prescriptions ⁤filled, including vaccinations.”Walgreens has lost customer share in areas like beauty and‍ personal care. Some of‌ this is because ‍prices remain⁤ too high and are uncompetitive –‍ something⁣ more and more shoppers won’t ‍tolerate in the current environment,” GlobalData Managing Director ​Neil Saunders said.Reporting by Khushi Mandowara and ⁢Leroy Leo in Bengaluru; Editing by Pooja DesaiOur Standards: The Thomson Reuters Trust Principles. ‌Acquire Licensing Rights, opens new ​tab

Link from www.reuters.com

Exit mobile version